ATRIDE debuts its next-generation smart breathing shirt, effectively a “Holter for the lungs.” This wearable delivers medical wellness grade respiratory and stress insights directly from the lungs via embedded nanotech sensors and advanced e-textile engineering, enabling continuous, non-invasive lung mapping, early anomaly detection, and telecare support.
When & Where:
May 27–30, 2025 at Web Summit Vancouver as a BETA startup. This marks ATRIDE’s second Web Summit appearance, following a successful debut in Lisbon.
Why It Matters:
As a CE-certified medical-wellness wearable for lung monitoring, the shirt bridges clinical accuracy with everyday comfort. Continuous data empowers patients and clinicians with actionable insights—vital for managing COPD, asthma, stress, and athletic performance—without ever stepping into a lab.
Who:
- Maarten Gijssel, Chief Clinical Officer (EU)
- Vangelis Lympouridis, PhD, Chief Technology Officer (USA)
- Maria Kontogiorgou, CEO & Head of Digital Experience Design ( UK/EU)
Their combined expertise drives ATRIDE’s mission to democratize respiratory care globally.
Ongoing Research & Validation:
ATRIDE is launching multicenter studies in the UK, Netherlands, and Greece-leveraging Greece’s 227 inhabited islands as a real-world telecare ecosystem. A €1.1 million EISMEA-funded pilot has already deployed shirts to monitor 150+ COPD and asthma patients remotely, validating scalable, lab-grade telehealth solutions.
Media Contact:
info@atride.eu | +44 75 30151612
Website: www.atride.eu
